mRNA vaccine - ClearB Therapeutics
Alternative Names: ClearB Therapeutics - mRNA vaccineLatest Information Update: 03 Dec 2024
Price :
$50 *
At a glance
- Originator ClearB Therapeutics
- Class Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Hepatitis B
Most Recent Events
- 05 Jun 2024 Preclinical trials in Hepatitis B in USA, before June 2024 (IV)
- 05 Jun 2024 Pharmacodynamics data from preclinical studies for Hepatitis B presented at the European Association for the Study of the Liver Congress 2024 (EASL-2024)
- 05 Jun 2024 Pharmacodynamics data from preclinical studies for Hepatitis B presented at the European Association for the Study of the Liver Congress 2024 (EASL-2024)